Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial

Fig. 2

The KM curves of A PFS and B OS before and after IPTW analyses according to the low or high NLR in TH group. The KM curves of C PFS and D OS before and after IPTW analyses according to the low or high NLR in THP group. Abbreviations: KM, Kaplan–Meier; PFS, progression-free survival; OS, overall survival; IPTW, inverse probability of treatment weighting; TH group, trastuzumab plus docetaxel group; THP group, pertuzumab plus trastuzumab plus docetaxel

Back to article page